Chiemi Kamakura, Representative Director & CEO of Agatha Inc., Receives the “Best of GCP Expert Award” from the Japanese Society of Clinical Trials and Research

Agatha Inc. is pleased to announce that its Representative Director & CEO, Chiemi Kamakura, has received the “Best of GCP Expert Award” presented by the Japanese Society of Clinical Trials and Research. This Award recognizes individuals or organizations who hold GCP (Good Clinical Practice) Expert certification, have been active as GCP Experts for more than five years, and have made significant contributions to the management and development of the Society. Recipients are selected through a review by the Award Selection Committee and are officially approved by the Board of Directors. Ms. Kamakura was recognized for her contributions as a GCP Expert to the operation and advancement of the Society, which led to this award. The Award was presented at the 17th Annual Meeting of the Japanese Society of Clinical Trials and Research, at the Kobe International Conference Center.

Comment from Chiemi Kamakura, Representative Director & CEO

I am deeply honored and sincerely grateful to receive the prestigious “Best of GCP Expert Award” from the Japanese Society of Clinical Trials and Research. I believe this Award recognizes not only my personal activities, but also the collective efforts made together with the Society and its members to improve the quality and efficiency of clinical trials, as well as the steady progress achieved together with the employees of Agatha. At Agatha, we consider it our important responsibility to support an environment in which the principles of GCP are properly implemented in practice and all professionals involved in clinical trials can focus on their work with confidence and peace of mind. Encouraged by this Award, we will continue to collaborate with the Society and related stakeholders to further enhance the reliability and efficiency of clinical trials and contribute to the sustainable development of the Society.

About the Japanese Society of Clinical Trials and Research

The Japanese Society of Clinical Trials and Research is an academic organization dedicated to the advancement of both the science and practice of clinical trials. Through the promotion and advancement of GCP, human resource development, and academic exchange, the Society contributes to improving the quality of clinical trials in Japan.

About Agatha Inc.

Founded in 2015, with the vision of contributing to the improvement, acceleration, and efficiency of clinical trials, clinical research, and manufacturing quality by providing “Agatha,” a cloud-based service for sharing, managing, and storing documents related to clinical trials and quality management. The service is provided to medical institutions, pharmaceutical companies, biotechs, medical device companies, CROs, SMOs, and clinical laboratories.

With offices in Lyon, Tokyo and Boston Agatha enables more than 400 life science companies and 70,000 users worldwide to streamline their document management, structure clinical study documentation, and secure their quality processes.

Agatha's applications provide highly efficient and easy-to-use solutions, as they are immediately available online and compliant with key regulations such as FDA CFR 21 Part 11, GDPR, and EU Annex 11.

• Company Name: Agatha Inc.
• CEO: Chiemi Kamakura
• Address: Kabuto One 9F WeWork, 7-1 Nihonbashi Kabutocho, Chuo-ku, Tokyo 103-0026
• Capital: 1.094 billion yen (including capital reserve)
• Established: October 2, 2015
• Website: https://www.en.agathalife.com

For Media Inquiries:
Contact: Marion Béhier
Tel : +33687896308
Email: [email protected]